Novartis CAR-T therapy Kymriah has been approved by the European Commission for use in patients up to 25 years of age with ALL. Newcastle is one of the first three NHS hospitals to apply to use the CAR-T (chimeric antigen receptor T-cell) therapy.

https://www.bbc.co.uk/news/health-41094990